K. Wittrup
Gründer bei Adimab LLC
Profil
K.
Dane Wittrup is the founder of Sesen Bio, Inc. (founded in 2008) and Adimab LLC (founded in 2007), where he holds the title of Chief Scientific Officer.
Dr. Wittrup is also the founder of BioDisplay Technologies, Inc., xCella Biosciences, Inc., Immunitas Therapeutics, Inc., Ankyra Therapeutics, Inc., 76Bio, Inc. Dr. Wittrup's current job(s) include being the Chairman of SAB Corp., a Professor at the Massachusetts Institute of Technology (since 2011), an Advisor at Longwood Fund Management LLC, and a Professor at the David H.
Koch Institute for Integrative Cancer Research.
Dr. Wittrup's former job includes being a Professor at the University of Illinois.
Dr. Wittrup's education history includes a graduate and doctorate degree from the California Institute of Technology and an undergraduate degree from The University of New Mexico.
Aktive Positionen von K. Wittrup
Unternehmen | Position | Beginn |
---|---|---|
SAB Corp. | Vorsitzender | 06.10.2009 |
Massachusetts Institute of Technology | Corporate Officer/Principal | 06.10.2009 |
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Gründer | 06.10.2009 |
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Gründer | - |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Berater | - |
Ehemalige bekannte Positionen von K. Wittrup
Unternehmen | Position | Ende |
---|---|---|
Ankyra Therapeutics, Inc.
Ankyra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Ankyra Therapeutics, Inc. engages in the provision of healthcare services. The company is headquartered in Boston, MA. | Gründer | - |
xCella Biosciences, Inc.
xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Gründer | - |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Gründer | - |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von K. Wittrup
California Institute of Technology | Doctorate Degree |
The University of New Mexico | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 10 |
---|---|
SAB Corp. | |
BioDisplay Technologies, Inc.
BioDisplay Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., BioDisplay Technologies, Inc. is a company that provides medical research services. The company is based in Savoy, IL. The company was founded by Christopher Taron, K. Dane Wittrup. BioDisplay Technologies was acquired by Abbott Laboratories on December 21, 2001 for $7 million. | Commercial Services |
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Health Technology |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Commercial Services |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Health Technology |
xCella Biosciences, Inc.
xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Health Technology |
Ankyra Therapeutics, Inc.
Ankyra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Ankyra Therapeutics, Inc. engages in the provision of healthcare services. The company is headquartered in Boston, MA. | Health Services |
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Health Technology |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Finance |